ICU Medical Statistics
Total Valuation
ICU Medical has a market cap or net worth of $2.86 billion. The enterprise value is $4.23 billion.
| Market Cap | 2.86B |
| Enterprise Value | 4.23B |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, after market close.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 24.37 million shares outstanding. The number of shares has increased by 0.87% in one year.
| Shares Outstanding | 24.37M |
| Shares Change (YoY) | +0.87% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 12.87% |
| Owned by Institutions (%) | 93.53% |
| Float | 21.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 22.00 |
| PS Ratio | 1.27 |
| Forward PS | 1.22 |
| PB Ratio | 1.38 |
| P/FCF Ratio | 37.24 |
| PEG Ratio | 0.99 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.27, with an EV/FCF ratio of 55.00.
| EV / Earnings | n/a |
| EV / Sales | 1.87 |
| EV / EBITDA | 17.27 |
| EV / EBIT | n/a |
| EV / FCF | 55.00 |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.78.
| Current Ratio | 2.61 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 6.60 |
| Debt / FCF | 21.03 |
| Interest Coverage | -0.05 |
Financial Efficiency
Return on equity (ROE) is -2.80% and return on invested capital (ROIC) is -0.34%.
| Return on Equity (ROE) | -2.80% |
| Return on Assets (ROA) | -1.40% |
| Return on Capital (ROIC) | -0.34% |
| Revenue Per Employee | $161,224 |
| Profits Per Employee | -$4,237 |
| Employee Count | 14,000 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.12 |
Taxes
| Income Tax | -42.36M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.64% in the last 52 weeks. The beta is 0.74, so ICU Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -32.64% |
| 50-Day Moving Average | 107.16 |
| 200-Day Moving Average | 102.02 |
| Relative Strength Index (RSI) | 58.33 |
| Average Volume (20 Days) | 445,303 |
Short Selling Information
The latest short interest is 1.32 million, so 5.42% of the outstanding shares have been sold short.
| Short Interest | 1.32M |
| Short Previous Month | 1.18M |
| Short % of Shares Out | 5.42% |
| Short % of Float | 6.22% |
| Short Ratio (days to cover) | 6.33 |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.26 billion and -$59.31 million in losses. Loss per share was -$2.45.
| Revenue | 2.26B |
| Gross Profit | 733.08M |
| Operating Income | -12.48M |
| Pretax Income | -101.68M |
| Net Income | -59.31M |
| EBITDA | 244.95M |
| EBIT | -5.20M |
| Loss Per Share | -$2.45 |
Balance Sheet
The company has $251.42 million in cash and $1.62 billion in debt, giving a net cash position of -$1.37 billion or -$56.06 per share.
| Cash & Cash Equivalents | 251.42M |
| Total Debt | 1.62B |
| Net Cash | -1.37B |
| Net Cash Per Share | -$56.06 |
| Equity (Book Value) | 2.07B |
| Book Value Per Share | 84.87 |
| Working Capital | 732.37M |
Cash Flow
In the last 12 months, operating cash flow was $170.75 million and capital expenditures -$93.85 million, giving a free cash flow of $76.90 million.
| Operating Cash Flow | 170.75M |
| Capital Expenditures | -93.85M |
| Free Cash Flow | 76.90M |
| FCF Per Share | $3.18 |
Margins
Gross margin is 32.48%, with operating and profit margins of -0.55% and -2.63%.
| Gross Margin | 32.48% |
| Operating Margin | -0.55% |
| Pretax Margin | -4.50% |
| Profit Margin | -2.63% |
| EBITDA Margin | 10.85% |
| EBIT Margin | -0.23% |
| FCF Margin | 3.41% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.87% |
| Shareholder Yield | -0.87% |
| Earnings Yield | -2.07% |
| FCF Yield | 2.69% |
Analyst Forecast
The average price target for ICU Medical is $127.00, which is 8.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $127.00 |
| Price Target Difference | 8.06% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 2.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 3:2.
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 3:2 |
Scores
ICU Medical has an Altman Z-Score of 1.75 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.75 |
| Piotroski F-Score | 5 |